On March 29, 2020 the U.S. Department of Health and Human Services issued a statement that they have “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics…
Continue Reading
TMA’s Global Myositis Patient Conference – Celebrating Our Worldwide Community!Register Now!
On March 29, 2020 the U.S. Department of Health and Human Services issued a statement that they have “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics…
Continue ReadingOn March 19, it was announced that chloroquine and hydroxychloroquine were showing promise in the treatment for COVID 19. However, there are no available data from randomized clinical trials to…
Continue ReadingTom Lloyd, MD PhDAssociate Professor of Neurology and Neuroscience at Johns Hopkins University, Co-Director of the Johns Hopkins Myositis Center In a press conference today, President Trump discussed what the…
Continue ReadingCoronavirus disease also known as (COVID-19) is a respiratory illness that can spread from person to person. Symptoms include fever, cough, shortness of breath. The virus can lead to pneumonia…
Continue ReadingA recent article published in the Courier Newsroom discussed the challenges of caring for those with chronic illnesses and the economic and financial burdens that families face when dealing with…
Continue Reading